Navigation Links
Sangamo BioSciences Announces Presentation at the Future Leaders in the Biotech Industry Conference
Date:4/12/2012

RICHMOND, Calif., April 12, 2012 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the progress of Sangamo's ZFP Therapeutic® development programs and an overview of the company's business strategy at 1:30 pm ET on Friday, April 20, 2012, at the Future Leaders in the Biotech Industry Conference which will be held in New York City.

The presentation will be webcast live and may be accessed via a link on the Sangamo BioSciences website in the Investor Relations section http://investor.sangamo.com/index.cfm under Events and Presentations. The presentation will be archived on the Sangamo website for two weeks after the event.

About Sangamo

Sangamo BioSciences, Inc. is focused on research and development of novel DNA-binding proteins for therapeutic gene regulation and genome editing. It has ongoing Phase 2 and Phase 1/2 clinical trials to evaluate the safety and efficacy of a novel ZFP Therapeutic® for the treatment of HIV/AIDS. Sangamo's other therapeutic programs are focused on monogenic diseases, including hemophilia and hemoglobinopathies such as sickle cell anemia and beta-thalassemia, and a program in Parkinson's disease. Sangamo's core competencies enable the engineering of a class of DNA-binding proteins known as zinc finger DNA-binding proteins (ZFPs).  Engineering of ZFPs that recognize a specific DNA sequence enables the creation of sequence-specific ZFP Nucleases (ZFNs) for gene modification and ZFP transcription factors (ZFP TFs) that can control gene expression and, consequently, cell function.  Sangamo has entered into a strategic collaboration with Shire to develop therapeutics for hemophilia and other monogenic diseases and has established strategic partnershi
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine technology :

1. Sangamo BioSciences Announces Presentation at the Sixth Annual JMP Securities Healthcare Conference
2. Sangamo BioSciences and Collaborators Present Data Showcasing Broad Applications of ZFP Therapeutics®
3. Sangamo BioSciences Announces Presentation at the Cowen and Company 31st Annual Health Care Conference
4. Sangamo BioSciences Announces Presentation of Positive Clinical Data From Novel ZFN Therapeutic Approach for the Treatment of HIV/AIDs at Conference for Retroviral and Opportunistic Infections
5. Sangamo BioSciences Announces Presentation at the 13th Annual BIO CEO & Investor Conference
6. Sangamo BioSciences Announces Presentation of Phase 2 Data in Amyotrophic Lateral Sclerosis (ALS) at Society for Neuroscience Meeting
7. Sangamo BioSciences Announces Presentation at Lazard Capital Markets Healthcare Conference
8. Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant Human Stem Cells
9. Sangamo BioSciences Receives Michael J. Fox Foundation Funding to Develop Novel Drug for the Treatment of Parkinsons Disease
10. Sangamo BioSciences Announces First Quarter 2010 Conference Call and Webcast
11. Sangamo BioSciences Announces Fourth Quarter and Full Year 2009 Conference Call and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... 2013 Reaching a critical milestone in the ... of Boards of Pharmacy ® (NABP ® ) ... has passed the Internet Corporation for Assigned Names and ... .PHARMACY gTLD by the end of 2013, and will ... and related entities that are located in ...
(Date:5/21/2013)... 21, 2013 Valeant Pharmaceuticals ... ) (TSX: VRX) today announced the ... its 2013 annual meeting of shareholders ... vote for the election of directors ... Farmer235,731,9341,964,748Robert A. Ingram233,865,8763,830,806Theo Melas-Kyriazi237,081,508615,174G. Mason Morfit235,623,2832,073,399J. ...
(Date:5/21/2013)... de 2013 La junta directiva de ... OMNIlife science®, Inc., Enztec, Ltd. y Praxim, SA, han ... Mayer, un ejecutivo ortopédico experimentado, será vicepresidente de ... , un experto refutado en dispositivos médicos, ... unirse a OSI como presidente de la junta, ...
Breaking Medicine Technology:NABP's .PHARMACY Proposal Passes Initial ICANN Evaluation 2NABP's .PHARMACY Proposal Passes Initial ICANN Evaluation 3Valeant Pharmaceuticals Announces 2013 Annual Meeting Results 2Orthopaedic Synergy, Inc. anuncia nuevas incorporaciones a la junta directiva 2Orthopaedic Synergy, Inc. anuncia nuevas incorporaciones a la junta directiva 3
... DIEGO, Sept. 8 ResMed Inc. (NYSE: RMD ... company,s outstanding shares of common stock, payable in the form ... 2010. The new total shares outstanding doubled to 151,388,240 shares, ... the company,s common stock on the New York Stock Exchange ...
... 8 Transgenomic, Inc. (OTC Bulletin Board: ... chief executive officer, will deliver the Company,s corporate presentation ... Conference on Monday, September 13 at 4:55 p.m. EDT. ... in New York City from September 13th – 15th, ...
Cached Medicine Technology:Transgenomic to Present at the Rodman & Renshaw 12th Annual Global Investment Conference 2Transgenomic to Present at the Rodman & Renshaw 12th Annual Global Investment Conference 3
(Date:5/21/2013)... (PRWEB) May 21, 2013 Phoseon Technology ... at the 20th Annual IMI European Ink Jet ... proven market leader, Phoseon continues to invest in product ... the adoption of UV LED curing in printing applications. ... families on the market offering both air cooled and ...
(Date:5/21/2013)... Global Proving Ground (GPG), a fast rising ... retailer of health and fitness supplements, are partnering up ... Island. “We cast the show by having millions ... our unique social networking platform,” states show’s creator James ... an island in the Pacific Ocean, where they must ...
(Date:5/21/2013)... Texas (PRWEB) May 21, 2013 ... With the help of Texas Counseling’s Sexuality and ... communication, and the development of healthier habits for ... workshops available for both couples and individuals at ... enhance their relationships and learn skills to develop ...
(Date:5/21/2013)... the roles two proteins, thrombospondin-1 and prosaposin, play ... has identified a five-amino acid fragment of prosaposin ... of prostate, breast and lung cancer. The findings ... metastasis in a variety of cancers. , ... at Boston Children,s Hospital, Vivek Mittal, PhD, at ...
(Date:5/21/2013)... University of Cincinnati (UC) researchers have identified a number ... help with earlier diagnosis and intervention in those who ... first of its kind and led by UC,s Bruce ... staff from Walter Reed National Military Medical Center at ... Orlando, Fla. , The DoDSR is a biological ...
Breaking Medicine News(10 mins):Health News:Bodybuilding.com Partners with Global Proving Ground’s New Reality Show Warrior Island 2Health News:Bodybuilding.com Partners with Global Proving Ground’s New Reality Show Warrior Island 3Health News:Workshops Offered To Identify Underlying Challenges That Put Strain On Relationships 2Health News:Changing cancer's environment to halt its spread 2Health News:Changing cancer's environment to halt its spread 3Health News:Biomarkers discovered for inflammatory bowel disease 2
... , , BOULDER, Colo., July 30 ... owning patented surgical technology that is emerging as a standard of ... quarter of fiscal year 2010. , , Net ... representing a 3% increase over net sales of $3.1 million for ...
... , SAO PAULO, July 30 Frost & Sullivan ... recipient of the 2009 Market Penetration Leadership Award ... offers a complete portfolio of solutions including digital and computed radiography, ... by the needs of customers willing to enter in the digital ...
... , , CHICAGO, July ... the world,s largest scientific/medical society dedicated to advancing research and ... of the human lifespan, unveils an innovative, technology-based fix to ... Increase the lifespan, or improve the healthspan, of all ...
... ... America, will award prizes to young filmmakers, 25 years of age and under, ... America. The top three winners will receive cash prizes of $5,000, $3,500 and ... 5-12 minutes creative films online, where the public will partake in the first ...
... ... provide students with an excellent option for a less expensive education in the thriving ... ... the nursing shortage creates opportunity for the qualified nurse, and online nursing degrees are ...
... DALLAS July 30, 2009 The typical dose ... is much too low to account for modern-day physiques, ... The finding, reported online and in the August edition ... important for those living in societies plagued by obesity, ...
Cached Medicine News:Health News:Encision Reports Profitable First Fiscal Quarter Results 2Health News:Encision Reports Profitable First Fiscal Quarter Results 3Health News:Encision Reports Profitable First Fiscal Quarter Results 4Health News:Frost & Sullivan Awards Agfa Healthcare for Brazilian Market Penetration Leadership in 2009 2Health News:Frost & Sullivan Awards Agfa Healthcare for Brazilian Market Penetration Leadership in 2009 3Health News:Obama White House Can Save $3.7 Trillion and Extend Lifespan 29+ Years, Predicts Revolutionary A4M Healthcare Plan 2Health News:Call to the Youth of America: Palms for Life Fund Launches Film Competition to Document Hunger in the United States 2Health News:All Nursing Schools Sheds Light on Online Nursing Degree Opportunities in a Rough Economy 2Health News:Higher drug doses needed to defeat tuberculosis, UT Southwestern researchers report 2Health News:Higher drug doses needed to defeat tuberculosis, UT Southwestern researchers report 3
... Mumps IgM Enzyme-Linked Immunosorbent Assay ... qualitative detection of IgM antibody ... for the determination of immunological ... this kit have not been ...
The DSL 05-10-MUM Mumps IgM Enzyme-Linked Immunosorbent Assay (ELISA) kit provides materials for the determination of IgM-class antibodies to Mumps virus in human serum. This assay is intended for in...
... announced the launch of the Chilli ... bi-directional cooled-tip catheter available in the United ... physicians the benefits of cooled ablation technology ... Boston Scientific Blazer(R) catheter platform. ,Cooled cardiac ...
... wire crosses the lesion first, independent of ... actions, including filter placement and retrieval, balloon ... the wire., ,Emboshield is designed to capture ... carotid stenting procedure, and it is the ...
Medicine Products: